New techniques for early detection of lung cancer

European Respiratory Journal, Supplement

Volumn 21, Issue 39, 2003, Pages

  Sutedja, G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Early detection; Early treatment; Lung cancer; New techniques

Indexed keywords

BIOLOGICAL MARKER; PHOTOSENSITIZING AGENT; TUMOR MARKER;

BRONCHOSCOPY; CANCER MORTALITY; CANCER SCREENING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; ECHOGRAPHY; EPIDEMIC; HUMAN; LUNG CANCER; LUNG DISEASE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SMOKING; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SPUTUM CYTODIAGNOSIS; SURVIVAL RATE; TECHNIQUE; THORAX RADIOGRAPHY; THORAX SURGERY; ENDOSCOPIC ECHOGRAPHY; LUNG TUMOR; MASS SCREENING; METHODOLOGY; REVIEW; RISK FACTOR;

BRONCHOSCOPY; CLINICAL TRIALS; ENDOSONOGRAPHY; HUMANS; LUNG NEOPLASMS; MASS SCREENING; MICROSCOPY, CONFOCAL; RISK FACTORS; TOMOGRAPHY, SPIRAL COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 0037243767     PISSN: 09041850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (108)

1. Hirsh FR, Franklin WA, Gazdar AF, Bunn PA. Early detection of lung cancer: Clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 2001; 7: 5-22.
2. Melamed MR, Flehinger BJ, Zaman MB. Impact of early detection on the clinical course of lung cancer. Surg Clin North Am 1987; 67: 909-924.
3. Kubik A, Parkin DM, Khlat M, Erban J, Polak J, Adamek M. Lack of benefit from semi-annual screening for cancer of the lung: Follow-up report of a randomized controlled trial on population of highrisk males in Czechoslovakia. Int J Cancer 1990; 45: 26-33.
4. Marcus PM, Bergstrahl EJ, Fagerstrom RM, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 2000; 92: 1308-1316.
5. Patz EF, Goodman PC, Bepler G. Screening for lung cancer. NEJM 2000; 343: 1627-1633.
6. Strauss GM, Gleason RE, Sugarbaker DJ. Screening for lung cancer: Another look, a different view. Chest 1997; 111: 754-768.
7. Jett JR. Pro/con editorials spiral computed tomography screening for lung cancer is ready for prime time. Am J Respir Crit Care Med 2001; 163: 812-815.
8. Patz EF, Goodman PC. Low-dose spiral computed tomography screening for lung cancer: not ready for prime time. Am J Respir Crit Care Med 2001; 163: 812-815.
9. Greenlee RT, Hill-Horman MB, Murray T, et al. Cancer statistics 2001. CA Cancer J Clin 2001; 51: 15-36.
10. Feld R, Rubinstein LV, Weisenberger TH, and the Lung Cancer Study Group. Sites of recurrence in resected stage I non-small-cell lung cancer. A guide for future studies. J Clin Oncol 1984; 2: 1352-1358.
11. Pairolero PC, William DE, Bergstrahl EJ, Piehler JM, Bernatz PE, Payne SW. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thor Surg 1984; 38: 331-338.
12. Martini N, Bains MS, Burt ME. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995; 109: 120-129.
13. Woolner LB, Fontana RS, Cortese DA. Roentgenographically occult lung cancer: Pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc 1984; 59: 453-466.
14. Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: The over-shadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 1989; 17: 691-694.
15. Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 1998; 90: 1335-1345.
16. Braun NM, Caporaso NE, Page WF, Hoover RN. Genetic component of lung cancer: cohort study of twins. Lancet 1994; 344: 440-443.
17. Slaughter D, Southwick HW, Smeijkal W. "Field cancerization" in oral stratified squamous epithelium. Cancer 1953; 6: 963-968.
18. Auerbach O, Stout AP, Hammond C, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N Engl J Med 1961; 265: 253-268.
19. Saccomano G, Archer VE, Auerbach O, Saunders RP. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 1974; 33: 256-270.
20. Auerbach O, Hammond C, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking 1955-1960 vs 1970-1977. N Engl J Med 1979; 300: 381-386.
21. Kerr KM. Pulmonary preinvasive neoplasia. J Clin Pathol 2001; 54: 257-271.
22. Minna JD. Molecular pathogenesis of lung cancer and the potential translational application of these results to the clinic. Lung Cancer 1997; 18: Suppl. 2, 73-74.
23. Lippman SM, Hong WK. The biology behind. Cancer prevention by delay. Clin Cancer Res 2002; 8: 305-313.
24. Thiberville L, Payne P, Vielkinds J, et al. Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res 1995; 55: 5133-5139.
25. Wistuba I, Behrens C, Milchgrub S, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999; 18: 643-650.
26. Payne PW, Sebo TJ. Doudkine A, et al. Sputum screening by quantitative microscopy: A reexamination of a portion of the National Cancer Institute Cooperative Early Lung Cancer Study. Mayo Clin Proc 1997; 72: 697-704.
27. Mao L, Lee JS, Kurie JM, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997; 89: 857-862.
28. Park IW, Wistuba II, Maitra A, et al. Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer. J Natl Cancer Inst 1999; 91: 1863-1868.
29. Gazdar A, Park I, Sood S, et al. Clonal patches of molecular changes in smoking damaged respiratory epithelium. Lung Cancer 2000; 29: S7.
30. Hayata Y, Kato H, Furuse K, Kusunoki Y, Suzuki S, Mimura S. Photodynamic therapy of 169 early stage cancers of the lung and oesophagus: a Japanese multicentre study. Laser Med Sci 1996; 11: 255-259.
31. Boxem TJ van, Venmans BJ, Postmus PE, Sutedja G. Curative endobronchial therapy in early-stage nonsmall cell lung cancer. J Bronchol 1999; 6: 198-206.
32. Hayata Y, Funatsu H, Kato H. Results of lung cancer screening programs in Japan: Early detection and localization of lung tumors in high risk groups. In: Band PR, ed. Recent Results of Cancer Research. Vol 82. Heidelberg, Springer Berlin, 1982; pp. 179-186.
33. Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: Screening and detection with low-dose spiral CT versus radiography. Radiology 1996; 201: 798-802.
34. Saito Y, Nagamoto N, Ota S. Results of surgical treatment for roentgenographically occult bronchogenic squamous cell carcinoma. J Thorac Cardiovasc Surg 1992; 104: 401-407.
35. Shimizu N, Ando A, Teramoto S, Moritani Y, Nishii K. Outcome of patients with lung cancer detected via mass screening as compared to those presenting with symptoms. J Surg Oncol 1992; 50: 7-11.
36. Endo C, Sagawa M, Sato M, et al. What kind of hilar lung cancer can be a candidate for segmentectomy with curative intent? Retrospective clinicopathological study of completely resected roentgenographically occult bronchogenic squmous cell carcinoma. Lung Cancer 1998; 21: 93-97.
37. Koike T, Terashima M, Takizawa T, et al. The influence of lung cancer mass screening on surgical results. Lung Cancer 1999; 24: 75-80.
38. Miura H, Konaka C, Kawate N, Tsuchida T, Kato H. Sputum cytology-positive, bronchoscopically negative adenocarcinoma of the lung. Chest 1992; 192: 1328-1332.
39. Flehinger BJ, Kimmel M, Melamed MR. The effect of surgical treatment on survival from early lung cancer: The impact of screening. Chest 1992; 101: 1013-1018.
40. Black WC. Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening. J Natl Cancer Inst 2000; 92: 1280-1282.
41. Juffs HG, Tannock IF. Screening trials are even more difficult than we thought they were. J Natl Cancer Inst 2002; 94: 156-157.
42. McFarlane MJ, Feinstein AR, Wells CK. Clinical features of lung cancer discovered as a postmortem "surprise". Chest 1986; 90: 520-523.
43. Ichinose Y, Yano T, Yokoyama H. The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small cell lung cancer. J Thorac Cadiovasc Surg 1994; 108: 684-686.
44. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995; 60: 6615-6623.
45. Cortese DA, Edell ES, Kinsey JH. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc 1997; 72: 595-602.
46. Schuneman HJ, Dorn J, Grant BJB, Winkelstein W, Trevison M. Pulmonary function is a long-term predictor of mortality in the general population. 29-year follow-up of the Buffalo Health Study. Chest 2000; 118: 656-664.
47. Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. Ann Int Med 1986; 105: 503-507.
48. Tockman MS, Anthonissen NR, Wright EC, Donithan MG, The Intermittent Positive Pressure Breathing Trial Group and the Johns Hopkins Lung Project For The Early Detection of Lung Cancer. Airways obstruction and the risk for lung cancer. Ann Int Med 1987; 106: 512-518.
49. Nakaichi K, Imai K, Hayashi S. Polymorphisms of the CYP1A1 and Glutathione S-tranferase genes associated with susceptibility to lung cancer in relation to cigarette dose in as Japanese population. Cancer Res 1993; 53: 2994-2999.
50. Kiyohara C, Otsu A, Shirakawa T, Fukuda S, Hopkin J. Genetic polymorphisms and lung cancer susceptibility: A review. Lung Cancer 2002; 37: 241-256.
51. Kato H, Horai T. A colour atlas of endoscopic diagnosis in early stage lung cancer. Wolfe, Aylesbury, England, 1992; p. 35.
52. Sone W, Takashima S, Li F, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998; 351: 1242-1245.
53. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung cancer action project: Overall design and findings from baseline screening, Lancet 1999; 354: 99-105.
54. van Klaveren RJ, Habbema JDF, Pedersen JH, de Koning HJ, Oudkerk M, Hoogsteden HC. Lung cancer screening by low-dose spiral computed tomography. Eur Respir J 2001; 18: 857-866.
55. Hirsch FR, Prindiville SA, Byers T, et al. Sputum cytology as a marker of risk for lung cancerpreliminary results from the University of Colorado high risk cohort study. http://www.asco.org.
56. Tockman MS, Mulshine JL, Piantadosi S, et al. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res 1997; 3: 2237-2246.
57. Hittelman WN. Clones and subclones in the lung cancer field. J Natl Cancer Inst 1999; 91: 1796-1799.
58. Ahrendt SA, Chow JT, Xu LH, et al. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 1999; 91: 332-339.
59. Ikeda N, MacAulay C, Lam S, et al. Malignancy associated changes in bronchial epithelial cells and clinical application as a biomarker. Lung Cancer 1998; 19: 161-166.
60. Marek W, Kotschy-Lang N, Muti A, et al. Can semiautomated image cytometry on induced sputum become a screening tool for lung cancer. Eur Resp J 2001; 18: 942-950.
61. Soda H, Tomita H, Kohno S, Oka M. Limitation of annual screening chest radiography for the diagnosis of lung cancer. A retrospective study. Cancer 1993; 72: 2341-2346.
62. Quenkel GBA, Kessels AGH, Goei R, Engelshoven JMA. Miss rate of lung cancer on the chest radiography in clinical practice. Chest 1999; 115: 720-724.
63. Sutedja G, Golding RP, Postmus PE. HRCT in patients referred for intraluminal bronchoscopic therapy with curative intent. Eur Resp J 1996; 9: 1020-1023.
64. Aquino SL, Vining DJ. Virtual bronchoscopy. Clin Ches Med 1999; 20: 725-530.
65. Sato M, Saito Y, Usuda K, Takahashi S, Sagawa M, Fujimura S. Occult lung cancer beyond bronchoscopic visibility in sputum cytology positive patients. Lung Cancer 1998; 20: 17-24.
66. Tanaka M, Takizawa H, Satoh M, Okada Y, Yamasawa F, Umeda A. Assessment of an ultrathin bronchoscope that allows cytodiagnosis of small airways. Chest 1994; 106: 1443-1447.
67. Hung J, Lam S, LeRiche JC, Palcic B. Autofluorescence of normal and malignant bronchial tissue. Lasers Surg Med 1991; 11: 99-105.
68. Lam S, MacAulay C, Hung J, LeRiche JC, Profio AE, Palcic B. Detection of dysplasia and CIS with a lung imaging fluorescence endoscopy device. J Thorac Cardiovasc Surg 1993; 105: 1035-1040.
69. Qu J, MacAulay C, Lam S, Palcic B. Laser-induced fluorescence spectroscopy at endoscopy: tissue optics, Monte Carlo modelling and in vivo measurements. Optical Engineering 1995; 34: 3334-3343.
70. Haussinger K, Pichler J, Stanzel F, et al. Autofluorescence bornchoscopy: the D-light system. In: Bolliger CT, Mathur PN, eds. Interventional bronchoscopy. Vol 30. Prog Respir Res Basel, Karger, 2000; pp. 243-252.
71. Kakihana M, Kim KI, Okunaka T, et al. Early detection of bronchial lesions using system of autofluorescence endoscopy (SAFE) 1000. Diagn Ther Endoscopy 1999; 5: 99-104.
72. McWilliams A, Le Riche J, MacAulay C, Lam S. Quantitative fluorescence bronchoscopy. IPA 8th World Congress of Photodynamic Medicine, Vancouver Canada, June 2001, Abstract P40. http://www.derm. ubc.ca/pdt2001/.
73. Lam S, Kennedy T, Unger M, et al. Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. Chest 1998; 113: 696-702.
74. Thiberville, Sutedja G, Vermijlen P. A multicenter European study using the light induced fluorescence endoscopy system to detect precancerous lesions in high-risk individuals. Eur Resp J 1999; 14: 2475.
75. Sutedja G, Venmans BJ, Smit EF, Postmus PE. Fluorescence bronchoscopy for early detection of lung cancer. A clinical perspective. Lung Cancer 2001; 34: 157-168.
76. Hirsch FR, Prindiville SA, Miller YE, et al. Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. J Natl Cancer Inst 2001; 93: 1385-1391.
77. Pierard P, Vermijlen P, Bosschaerts T, et al. Synchronous roentgenographically occult lung carcinoma in patients with resectable primary lung cancer. Chest 2000; 117: 779-785.
78. Keith RL, Miller YE, Genmill RM, et al. Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clin Cancer Res 2000; 6: 1616-1625.
79. Sutedja G, Codrington H, Risse EK, et al. Auto-fluorescence bronchoscopy improves staging of radio-grahically occult lung cancer and has an impact on therapeutic strategy. Chest 2001; 120: 1327-1332.
80. Venmans BJ, van Boxem TJ, Smit EF, Postmus PE, Sutedja G. Results of two years experience with fluorescence bronchoscopy in detection of preinvasive bronchial neoplasia. Diagn Ther Endoscopy 1999; 5: 77-84.
81. Lam S, LeRiche JC, Zheng Y, et al. Sex-related Differences in bronchial epithelial changes associated with tobacco smoking. J Natl Cancer Inst 1999; 91: 691-696.
82. Venmans BJ, Linden van der JC, Elbers JRJ, et al. Observer variability in histopathological reporting of bronchial biopsy specimens: influence on the results of AFB in detection of bronchial neoplasia. J Bronchol 2000; 7: 210-214.
83. Burnett RA, Howatson WR, Lang S, et al. Observer variability in histopathological reporting of non-small cell lung carcinoma on bronchial biopsy specimens. J Clin Pathol 1996; 49: 130-133.
84. Nicholson AG, Perry LJ, Cury PM, et al. Reproducibility of the WHO/IASLC grading system for pre-invasive squamous lesions of the bronchus: A study of inter-observer and intra-observer variation. Histopathology 2001; 38: 202-208.
85. Hirsch FR, Gazdar AF, Gabrielson E, Lam S, Franklin WA. Histopathologic evaluation of premalignant and early malignant bronchial lesions: an interactive program based on internet digital images to improve WHO criteria for early diagnosis of lung cancer and for monitoring chemoprevention studies -A SPORE collaborative project. Lung Cancer 2000; 29: Suppl. 2, 209.
86. Vo-Dinh T, Mathur PN. Optical diagnostic and therapeutic technologies in pulmonary medicine. In: Bolliger CT, Mathur PN, eds. Interventional bronchoscopy. Vol 30. Prog Respir Res Basel, Karger, 2000; pp. 267-279.
87. Wagnieres GA, Star WM, Wilson BC. In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem Photobiol 1998; 68: 603-632.
88. Fujimoto JG. Optical coherence tomography for the diagnosis of neoplasia. Lung Cancer 2000; 29: Suppl. 2, 89.
89. MacAulay CE, Guillaud M, LeRiche J, et al. 2D and 3D quantitative microscopy for preinvasive lung cancer. Lung Cancer 2000; 29: Suppl. 1, 252.
90. Bota S, Auliac J-B, Paris C, et al. Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy. Am J Respir Crit Care Med 2001; 164: 1688-1693.
91. Breuer RH, Elzinga EH, Risse J, et al. The natural course of preneoplastic lesions in bronchial epithelium - A longitudinal study. Am J Resp Crit Care Med 2002; 165: A403.
92. Lam S, MacAulay C, LeRiche J, et al. A randomized phase Iib trial of anethole dithiolethione in smokers with bronchial dysplasia. J Natl Cancer Inst 2002; 94: 1001-1009.
93. Venmans BJ, van Boxem TJ, Smit EF, Postmus PE, Sutedja G. Outcome of bronchial CIS. Chest 2000; 117: 1472-1576.
94. Baba M, Sekine Y, Suzuki M, et al. Correlation between endobronchial ultrasonography (EBUS) images and histologic findings in normal and tumor-invaded bronchial wall. Lung Cancer 2002; 35: 65-71.
95. Miyazu Y, Miyazawa T, Kurimoto N, Iwamoto Y, Kanoh K, Kohno N. Endobronchial ultrasonography in the assessment of centrally located early-stage lung cancer before photodynamic therapy. Am J Respir Crit Care Med 2002; 165: 832-837.
96. Herder GJ, Breuer RH, Comans EF, Risse EK, van Mourik JC, Postmus PE. Positron emission tomography scans can detect radiographically occult lung cancer in the central airways. J Clin Oncol 2001; 19: 4271-4272.
97. Nagamoto N, Saito Y, Ohta S, et al. Relationship of lymph node metastasis to primary tumor size and microscopic appearance of roentgenographically occult lung cancer. Am J Surg Pathol 1989; 13: 1009-1013.
98. Usuda K, Saito Y, Nagamoto N, et al. Relation between bronchoscopic findings and tumor size of roentgenographically occult bronchogenic squamous cell carcinoma. J Thorac Cardiovasc Surg 1993; 106: 1098-1103.
99. Akaogi E, Ogawa I, Mitsui K, et al. Endoscopic criteria of early squamous cell carcinoma of the bronchus. Cancer 1994; 74: 3113-3117.
100. Nakamura H, Kawasaki N, Hagiwara M, Ogata A, Kato H. Endoscopic evaluation of centrally located early squamous cell carcinoma of the lung. Cancer 2001; 91: 1412-1147.
101. Sutedja G, van Boxem AJ, Postmus PE. The curative potential of intraluminal bronchoscopic treatment for early-stage non-small-cell lung cancer. Clinical Lung Cancer 2001; 2: 264-270.
102. van Boxem TJ, Westerga J, Venmans BJ, Sutedja G. Photodynamic therapy, Nd-YAG laser and electrocautery for treating early-stage intraluminal cancer. Which to choose? Lung Cancer 2001; 31: 31-36.
103. Sutedja G, Lam S, LeRiche JC, Postmus PE. Response and pattern of failure after photodynamic therapy for intraluminal stage I lung cancer. J Bronchology 1994; 1: 295-298.
104. Kawaguchi T, Furuse K, Kawahara M, Sutedja G. Histological examination of bronchial mucosa after photodynamic therapy showing no selectivity of effect between tumour and normal mucosa. Lasers Med Sci 1998; 13: 265-270.
105. Kato H, Konaka C, Ono J, Hayata Y. Preoperative laser photodynamic threapy in combination with operation in lung cancer. J Thorac Cardiovasc Surg 1985; 90: 420-429.
106. Shankar S, George PJ, Hetzel MR. Elective resection of tumours of the trachea and main carina after endoscopic laser therapy. Thorax 1990; 45: 493-495.
107. Sutedja G, Baris G, Zoetmulder F, van Zandwijk N. High dose rate brachytherapy improves resectability in squamous cell lung cancer. Chest 1992; 102: 308-309.
108. Vonk Noordegraaf A, Postmus PE, Sutedja G. Bronchoscopic treatment of patients with radio-graphically occult lung cancer not eligible for surgical resection: A follow-up study. Lung Cancer 2003 (in press).